Cuba vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Cuba
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Cuba rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cuba
- South-East Asia (WHO region)
How they compare
Cuba currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Cuba's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 4 times across 19 shared years of data; in 2006 it was Cuba ahead.
Cuba ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.2% | 34.8% | 39.5% | Cuba |
| 2010s | 88.0% | 76.0% | 12.0% | Cuba |
| 2020s | 99.0% | 92.2% | 6.8% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cuba or South-East Asia (WHO region)?
- Cuba, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cuba and South-East Asia (WHO region)?
- 6.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and South-East Asia (WHO region)?
- 19 years are reported by both, from 2006 to 2024.
- How do Cuba and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cuba ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.